| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/10/2011 | CN101011499B Linaloe leaf extract, pharmaceutical and health care uses thereof |
| 08/09/2011 | US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans |
| 08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
| 08/09/2011 | US7994282 Card proteins involved in cell death regulation |
| 08/09/2011 | US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 08/09/2011 | US7994188 Compounds for treating inflammatory diseases |
| 08/09/2011 | US7994137 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy |
| 08/09/2011 | US7994134 Peptide-based compounds |
| 08/09/2011 | US7994128 Conotoxin peptides useful as inhibitors of neuronal amine transporters |
| 08/09/2011 | US7993878 Antibodies to human IL-1β |
| 08/09/2011 | US7993673 Fast acting paracetamol formulation containing a small amount of antacid |
| 08/09/2011 | US7993643 Using low density lipoprotein receptor specific immunoglobulin for treatment and prevention of athersclerotic, kidney and inflammatory disorders |
| 08/09/2011 | CA2688709C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2688695C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2688694C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2687924C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2474645C Compositions and methods for systemic inhibition of cartilage degradation |
| 08/09/2011 | CA2468811C Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders |
| 08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 08/09/2011 | CA2434484C Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances |
| 08/09/2011 | CA2432568C Benzoylpyridazines |
| 08/09/2011 | CA2370738C Uteroglobin in the treatment of iga mediated autoimmune disorders |
| 08/09/2011 | CA2350340C B-cell epitopes of hsp65 and uses thereof |
| 08/04/2011 | WO2011094579A2 Mushroom compositions and methods for making and using |
| 08/04/2011 | WO2011094431A1 Sustained-release nsaid/hmg coa reductase inhibitor compositions |
| 08/04/2011 | WO2011094426A1 Caspase inhibitors |
| 08/04/2011 | WO2011094389A2 Cxcr4 antagonists for imaging of cancer and inflammatory disorders |
| 08/04/2011 | WO2011094288A1 Pyrazolopyrazine kinase inhibitors |
| 08/04/2011 | WO2011094283A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | WO2011094273A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | WO2011094259A2 Cd127 binding proteins |
| 08/04/2011 | WO2011094008A1 Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| 08/04/2011 | WO2011093498A1 Loxoprofen-containing pharmaceutical composition |
| 08/04/2011 | WO2011093469A1 Expression promoter for redox-related factor |
| 08/04/2011 | WO2011093290A1 Anti-inflammatory agent |
| 08/04/2011 | WO2011092187A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/04/2011 | WO2011092140A1 Pyrazole compounds as crth2 antagonists |
| 08/04/2011 | WO2011092065A1 Nitric oxide releasing compounds for the treatment of neurophatic pain |
| 08/04/2011 | WO2011092061A1 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/04/2011 | WO2011035143A3 Methods and compositions for inhibiting rho-mediated diseases and conditions |
| 08/04/2011 | US20110191872 Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 08/04/2011 | US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/04/2011 | US20110190623 Thermally-activatable liposome compositions and methods for imaging, diagnosis and therapy |
| 08/04/2011 | US20110190399 Curcumin nanoparticles and methods of producing the same |
| 08/04/2011 | US20110190395 Novel sulphur containing lipids for use as food supplement or as medicament |
| 08/04/2011 | US20110190389 Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
| 08/04/2011 | US20110190388 Ursolic acid derivative and pharmaceutical composition thereof |
| 08/04/2011 | US20110190377 Method for producing a cell and/or tissue and/or disease phase specific medicament |
| 08/04/2011 | US20110190372 Compositions and methods for treating inflammatory disorders |
| 08/04/2011 | US20110190366 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
| 08/04/2011 | US20110190364 Benzimidazole modulators of vr1 |
| 08/04/2011 | US20110190347 Methods for treating neuropathic pain |
| 08/04/2011 | US20110190342 Glycine b antagonist |
| 08/04/2011 | US20110190336 Azabenzimidazolones |
| 08/04/2011 | US20110190329 Non-amidic linkers with branched termini as cgrp receptor antagonists |
| 08/04/2011 | US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 08/04/2011 | US20110190317 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 08/04/2011 | US20110190314 Pharmaceutical compositions and their methods of use |
| 08/04/2011 | US20110190305 Optically Pure Diastereomers of 10-Propargyl-10-Deazaaminopterin and Methods of Using Same |
| 08/04/2011 | US20110190303 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 08/04/2011 | US20110190302 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use |
| 08/04/2011 | US20110190300 Amide compounds and the use thereof |
| 08/04/2011 | US20110190294 Novel estrogen receptor ligands |
| 08/04/2011 | US20110190292 Heterobicyclic compounds useful as kinase inhibitors |
| 08/04/2011 | US20110190282 Novel vegf-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 08/04/2011 | US20110190260 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/04/2011 | US20110190258 Aryl benzylamine compounds |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190255 Heterocyclic compounds |
| 08/04/2011 | US20110190248 Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 08/04/2011 | US20110190247 Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| 08/04/2011 | US20110190242 Compositions and methods for the treatment of inflammatory disease |
| 08/04/2011 | US20110190240 Nuclear factor kappa b pathway inhibitor composition and use of same |
| 08/04/2011 | US20110190239 Bmi-1 protein expression modulators |
| 08/04/2011 | US20110190237 Macrocyclic Prodrug Compounds Useful as Therapeutics |
| 08/04/2011 | US20110190233 Anionic conjugates of glycosylated bacterial metabolite |
| 08/04/2011 | US20110190227 Antagonists of Prostaglandin D2 Receptors |
| 08/04/2011 | US20110190217 Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic epo short peptides |
| 08/04/2011 | US20110190214 Advantageous Salts of Mu-Opiate Receptor Peptides |
| 08/04/2011 | US20110190203 Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110190138 Methods and compositions for treating conditions |
| 08/04/2011 | US20110189309 Topical medicament |
| 08/04/2011 | US20110189269 Extended release composition containing tramadol |
| 08/04/2011 | US20110189239 Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same |
| 08/04/2011 | US20110189220 Mushroom compositions and methods for making and using |
| 08/04/2011 | US20110189212 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 08/04/2011 | US20110189207 Methods for soluble zalpha11 cytokine receptors |
| 08/04/2011 | US20110189198 Compositions and Methods for Diagnosing and Treating an Inflammation |
| 08/04/2011 | US20110189194 Use of cd95 inhibitors for the treatment of inflammatory disorders |
| 08/04/2011 | US20110189181 Use of agents derived from CEACAM1 for the treatment of inflammatory diseases |
| 08/04/2011 | US20110189177 Antibodies to vla-1 |
| 08/04/2011 | US20110189174 Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization |
| 08/04/2011 | US20110189172 Methods for the treatment of rheumatoid arthritis |
| 08/04/2011 | US20110189162 Modified Clostridial Toxins Comprising an Integrated Protease Cleavage Site-Binding Domain |
| 08/04/2011 | US20110189152 Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
| 08/04/2011 | US20110189149 New Uses of Lactic Acid Bacteria and Bifidobacteria |
| 08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
| 08/04/2011 | US20110189135 Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous system |
| 08/04/2011 | US20110189131 Active variants of the il-18 binding protein and medical uses thereof |